Xinghand Bio

Xinghan Bio, also known as Stellar Biotech, is a biotechnology company headquartered in Singapore and Hong Kong that focuses on the research, development, and commercialization of innovative pharmaceutical products and medical devices. The company operates across the entire drug lifecycle, including drug discovery, clinical trials, and market access, with a strategic focus on the Southeast Asian and global markets. Its research portfolio includes advanced therapeutic areas such as oncology, where it is developing antibody-drug conjugates (ADCs) targeting novel receptors like CCRL2 for high-risk hematological malignancies. Additionally, the company leverages its expertise in fermentation and biochemical processes to produce high-purity ingredients like lactic acid for pharmaceutical and personal care applications. Xinghan Bio emphasizes scientific innovation and strategic partnerships to improve global healthcare access and patient outcomes.